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Quorum sensing in Vibrio cholerae involves signaling between two-component sensor protein kinases and the
response regulator LuxO to control the expression of the master regulator HapR. HapR, in turn, plays a
central role in regulating a number of important processes, such as virulence gene expression and biofilm
formation. We have determined the crystal structure of HapR to 2.2-Å resolution. Its structure reveals a
dimeric, two-domain molecule with an all-helical structure that is strongly conserved with members of the TetR
family of transcriptional regulators. The N-terminal DNA-binding domain contains a helix-turn-helix DNA-
binding motif and alteration of certain residues in this domain completely abolishes the ability of HapR to bind
to DNA, alleviating repression of both virulence gene expression and biofilm formation. The C-terminal
dimerization domain contains a unique solvent accessible tunnel connected to an amphipathic cavity, which by
analogy with other TetR regulators, may serve as a binding pocket for an as-yet-unidentified ligand.
The gram-negative bacterium Vibrio cholerae is the causative
agent of the frequently fatal epidemic disease cholera. The ability
of V. cholerae to infect humans is dependent on the expression of
virulence factors including the toxin coregulated pilus (48), a
critical colonization factor, and cholera toxin. The expression of
these genes is dependent upon a transcriptional cascade that is
initiated at the tcpPH promoter by the regulators AphA and
AphB (26, 45). AphA, which is a member of a new and relatively
uncharacterized regulatory family, activates tcpPH expression by
facilitating the binding of the LysR-type regulator, AphB, to the
promoter (23). The crystal structure of AphA, which has recently
been reported by our group, revealed that it is a winged helix
DNA-binding protein with an unusual C-terminal antiparallel
coiled-coil dimerization domain (7).
Quorum sensing is a process of bacterial cell-cell communi-
cation that influences gene expression in a cell density-depen-
dent manner (34). Both gram-negative and gram-positive bac-
teria use quorum sensing to regulate several physiological
functions, including bioluminescence, virulence factor expres-
sion, antibiotic production, and biofilm development (34). In
most gram-negative bacteria, the quorum-sensing circuit re-
sembles that of the symbiotic bacterium Vibrio fischeri (12),
where a LuxI-type protein synthesizes a specific acylated ho-
moserine lactone signaling molecule known as autoinducer. As
the cell density increases, the concentration of autoinducer
increases and, upon reaching a critical threshold concentration
both intra- and extracellularly, it binds to a soluble LuxR-type
protein that then activates gene expression. Other examples of
this circuit include the TraI/TraR system of Agrobacterium
tumefaciens (40, 50), and the LasI/LasR system of Pseudomo-
nas aeruginosa (5).
The quorum-sensing circuit of V. cholerae is significantly
more complex than that of the V. fischeri-type circuit and is
similar to that of the free-living marine bacterium Vibrio har-
veyi. At least two different autoinducers, CAI-1 and AI-2, are
synthesized by the enzymes CqsA and LuxS, respectively,
which share no homology to the LuxI family of autoinducer
synthases (35). As the cell density increases, these autoinduc-
ers are detected by the cognate sensors CqsS and LuxPQ,
respectively, which are hybrid, two-component sensor protein
kinases controlling the activity of the response regulator LuxO
through phosphorylation (30, 35, 51). LuxO, in turn, activates
the expression of four small RNAs (qrr1 to -4) that control the
expression of the transcriptional regulator HapR (also called
LuxR in V. harveyi and not related to the V. fischeri LuxR
protein) by influencing the stability of its mRNA (29). At high
cell density, LuxO is unphosphorylated and unable to activate
the expression of the small RNAs, thus allowing HapR and
LuxR to accumulate and influence gene expression.
V. cholerae HapR and V. harveyi LuxR proteins regulate a
number of important cellular processes via quorum sensing. At
high cell density, HapR represses both virulence gene expres-
sion (35, 51) and biofilm formation (16). This regulation is the
reverse of most other quorum-sensing systems in which viru-
lence and biofilm formation are induced at high cell density
and is thought to contribute to the self-limiting nature of chol-
era infections. HapR represses virulence gene expression by
binding to a specific site in the aphA promoter between posi-
tions 85 and 58 (25). This reduces the intracellular levels of
AphA and prevents activation of the virulence cascade. The
mechanism by which HapR represses biofilm formation is not
yet known. HapR also activates the expression of a hemagglu-
tinin referred to as HA/protease (20) and a newly discovered
transcriptional regulator involved in natural competence for
DNA uptake (32). LuxR regulates bioluminescence in V. har-
veyi by activating the expression of the luxCDABE operon (47).
V. cholerae HapR is a dimeric, 203-residue (23.6-kDa) pro-
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tein that is 71% identical to V. harveyi LuxR (20). To further
understand the molecular basis of HapR-mediated regulation
of virulence gene expression, we have determined its crystal
structure to 2.2-Å resolution. The all-helical structure reveals
the presence of an N-terminal helix-turn-helix (HTH) DNA-
binding motif and a large C-terminal dimerization domain that
is similar to a number of other TetR family regulators (9, 17,
37, 43). The dimerization interface contains a unique solvent
accessible tunnel that connects to an amphipathic cavity in
each monomer and which may serve as a ligand-binding pocket
for an unidentified small molecule effector.
MATERIALS AND METHODS
Protein preparation and crystallization. The purification of HapR using the
IMPACT-CN protein fusion and purification system (New England Biolabs) was
previously described (31). The protein was concentrated to 5 mg ml1 using
Centricons (Millipore) and dialyzed overnight in 20 mM Tris-HCl (pH 7.6), 1
mM EDTA, 200 mM NaCl, and 0.1 mM dithiothreitol. HapR crystals were
obtained using the vapor diffusion method by mixing equal volumes of the
protein as described above with 0.2 M HEPES (pH 7.5), 12% (wt/vol) polyeth-
ylene glycol 8000, and 5% (vol/vol) ethylene glycol as the crystallization buffer.
To determine the structure using the multi-wavelength anomalous dispersion
method (MAD), a heavy atom derivative was obtained by soaking the native
crystals in 1 mM ethylmercuricthiosalisylic acid (EMTS) for 6 h. For both native
and derivative crystals, 20% glycerol was used as the cryoprotectant.
Data collection and structure solution. A MAD data set was collected at NSLS
beamline X6A at three wavelengths (peak, 1.00595 Å; inflection, 1.009068 Å; and
remote, 0.93927 Å). After analysis with the program XDS (22), it was noted that
the anomalous signal was absent in the second and third wavelength sweeps.
Although unusual, such loss of anomalous signal is not unprecedented and has
been attributed to radiation-induced cleavage of S–Hg bonds (41). Based on this
phenomenon, a technique has been described for solving crystal structures using
radiation damage-induced phasing with anomalous scattering (RIPAS) (41). We
therefore adjusted our solution strategy to use this technique using the Hg-peak
sweep as the “derivative” data set and the inflection sweep as the “native” data
set (Table 1). Using these data, phases were obtained, the structure was solved,
and an initial electron density map was calculated to 2.9 Å using the SOLVE/
RESOLVE program (49) with scripts modified from a standard SIRAS (for
single isomorphous replacement with anomalous scattering) solution. The qual-
ity of the resulting electron density map was excellent (Fig. 1), and the presence
of a large number of tryptophan, tyrosine, and phenylalanine side chains allowed
placement of the HapR sequence into the map. Approximately 70% of the model
was built by using the software package O (21), and this starting model was
completed by iterative rounds of refinement with CNS (3), followed by model
rebuilding using 2Fo-Fc and Fo-Fc electron density maps. A 2.2-Å native data set
(Table 1), collected at NSLS beamline X6A, was used to complete the model by
iterations of manual rebuilding with the program COOT (11) and refinement
using REFMAC5 (1) with four TLS groups made up of the two DNA-binding
regions (A5 to A59, B5 to B59) and two dimerization domains (A60 to A199, B60
to B201). The final structure contains amino acids A5 to A201 in one monomer
and B5 to B201 in the other monomer and has an Rwork value of 23.0% and an
Rfree value of 26.3%. (see Table 1). A composite omit map, generated with CNS,
shows the main chain density to be complete for the entire structure; however,
side chain density is missing for residues A37, A123, A125, A156, A157, B37,
B99, B123, and B185. Analysis of the final structure with PROCHECK showed
91.0% of residues in the most favored regions and 9.0% in additionally allowed
regions. No residues were in generously allowed or disallowed regions.
Construction of point mutations and immunoblot analysis. The point muta-
tions in hapR were constructed by overlapping PCR using the primers H53C
(5-GATCGCTCTTCGGTGTTCAACTACTTCCCAACTC) and H55C (5-GA
TCGCTCTTCGAACTACTTCCCAACTCGTGAAG) with HapX (5-GATCG
TCTAGACGGATGCGCCCTTTGTGCTG) and the primers H53A (5-GATC
GCTCTTCGCACTGCTGCAACGGAGACTTGCGCAATC) and H55A (5-G
ATCGCTCTTCGGTTGGCCACTGTTGCAACGGAGACTTG) with HapE
(5-GATCGGAATTCACCATGGACGCATCAATCGAAAAACG). The re-
sulting fragments were ligated into pMMB66EH (14), and the mutations were
confirmed by DNA sequencing. The mutant hapR genes were then PCR ampli-
fied as previously described for the wild-type hapR gene (31) and ligated into
pTXB1, generating pWEL121 (T53A) and pWEL122 (F55A). The mutant pro-
teins were purified as described for the wild-type protein (31). The point muta-
tions were also inserted into the vector pKAS154 (25), generating pWEL129
(T53A) and pWEL130 (F55A). They were then introduced into the chromosome
of the V. cholerae aphA-lacZ fusion GK178 (25) by allelic exchange (46). Whole-
cell extracts of HapR and its mutant derivatives in GK178 were prepared by
growing the strains under AKI conditions (19) at 37°C for 5.5 h. After centrif-
ugation and resuspension in sodium dodecyl sulfate sample buffer, they were
subjected to sodium dodecyl sulfate–12.5% polyacrylamide gel electrophoresis,
transferred to nitrocellulose, and visualized by using an enhanced chemilumi-
nescence detection system (Amersham). Anti-HapR antibody was generated at
the Pocono Rabbit Farms from the purified protein (31) according to established
protocols. The stability of the F55A mutant was also assessed by comparing the
red shift in tryptophan fluorescence emission wavelength to wild-type protein in
TABLE 1. Data collection, phasing, and refinement statistics
Category
Data set
Native used for refinement “Native” used for phasing “Derivative” used for phasing
Data collection
Space group P212121 P212121 P212121
Unit cell dimensions (Å) a  43.8, b  85.1, c  110.4;
      90°
a  44.8, b  86.2, c  110.2;
      90°
a  44.8, b  86.2, c  110.2;
      90°
Resolution range (Å)a 67.2–2.2 (2.3–2.2) 20–2.9 (3.0–2.9) 20–2.5 (2.6–2.5)
Wavelength (Å) 1.0093 0.9392 1.0059
Measured reflections 86,355 (10,507) 93,638 (9,120) 144,148 (16,022)
Unique reflections 42,360 (5,265) 18,234 (1,783) 28,427 (3,118)
Multiplicity 2.0 (2.0) 5.1 (5.1) 5.1 (5.1)
Completeness (%) 98.3 (98.3) 99.6 (100.0) 99.6 (100.0)
Rsym
b (%) 4.7 (30.9) 5.0 (28.2) 7.5 (24.8)
Phasing
Resolution range (Å) 19.79–2.9
Overall figure of merit 0.70
Refinement
Resolution range (Å) 67.2–2.2
Rcryst/Rfree (%) 23.0/26.3
RMS deviation bonds (Å)/
angles (°)
0.041/3.189
No. of atoms (protein/solvent) 3,237/322
Avg B factors (Å2) 47.3
a Values in parentheses are for data in the highest-resolution shell.
b Rsym  100  	h	i  I(h)  Ii(h)  / 	h	i Ii(h), where Ii(h) and I(h) values are the ith and mean measurements of the intensity of reflection h.
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the presence of urea concentrations up to 7.2 M. The data (not shown) indicate
similar stabilities for the wild-type and mutant proteins.
Gel mobility shift and -galactosidase assays. The 117-bp DNA fragment for
the gel mobility shift assays was amplified by PCR from the aphA promoter of V.
cholerae C6706 str2 using primers extending from 173 (YF13) to 56 (YF22)
relative to the transcriptional start (25). The fragment was gel purified and end
labeled with digoxigenin as previously described (24). Binding reactions for
HapR were as previously described (25). The samples were applied to a 5%
polyacrylamide gel and subjected to electrophoresis in 0.5 Tris-borate-EDTA
at room temperature. The DNA was transferred to nylon membranes by elec-
troblotting, probed with anti-digoxigenin-AP antibody (Amersham Pharmacia),
and visualized by using chemiluminescence. -Galactosidase assays were carried
out as previously described (33).
The atomic coordinates and structure factors (PDB #2PBX) for HapR have
been deposited in the Protein Data Bank (PDB), Research Collaboratory for
Structural Bioinformatics (http://www.rscb.org).
RESULTS AND DISCUSSION
Overall structure and similarity to other TetR regulators.
The crystal structure of HapR was determined by RIPAS (41)
and subsequently refined to 2.2-Å resolution (Table 1 and Fig.
1A and B). The asymmetric unit contains a dimer in which the
two subunits are related by a noncrystallographic twofold ro-
tation axis. Each monomer of HapR is 31 Å long by 28 Å wide
by 56 Å deep, resulting in a dimer with overall dimensions of
64 Å by 28 Å by 56 Å. Each monomer contains nine  helices:
1 (15 to 32), 2 (40 to 47), 3 (52 to 57), 4 (61 to 83), 5 (90
to 106), 6 (110 to 119), 7 (126 to 151), 8 (160–180), and 9
(184 to 196) (Fig. 1A and B). The first three helices of each
HapR monomer form a putative DNA-binding domain, con-
taining a characteristic HTH motif (2 and 3). The large
C-terminal domain of HapR is composed of six  helices (4 to
9) and is involved in the dimerization of the repressor. The
overall fold of HapR is very similar to other members of the
TetR superfamily, including the Escherichia coli tetracycline
repressor TetR (17, 38), Staphylococcus aureus multidrug bind-
ing transcriptional regulator QacR (43, 44), Streptomyces coeli-
color -butyrolactone autoregulator receptor protein CprB
(36, 37), and Mycobacterium tuberculosis ethA repressor EthR
(9, 13). These proteins share the greatest degree of sequence
similarity in the N-terminal DNA-binding domain (Fig. 2). The
sequences of the C-terminal regulatory domains show low sim-
ilarity despite their overall conserved three-dimensional fold,
most likely reflecting differences in the specific ligands recog-
nized by the proteins.
In order to identify the closest structural homologues to
FIG. 1. Structure of HapR. (A) HapR monomer viewed from the side. The DNA binding surface is at the bottom in this orientation. Helices are
rainbow-colored according to the secondary structure succession from blue for the N-terminal helix 1 to red for C-terminal helix 9. Secondary structural
elements are labeled accordingly. Helix 3 residues T53 and F55, which have been mutated in the present study, are shown in magenta. The N and C
termini are indicated. (B) Side view of the HapR dimer, with one chain in magenta and one chain colored as in panel A. (C) View of the final HapR
model showing 2.9-Å electron density at 1.0
 from the initial, experimentally phased, and solvent-flattened electron density map obtained directly from
RESOLVE (49). (D) The same view of the final HapR model showing 2.2-Å electron density from a composite omit map calculated with CNS (3) using
the final model, contoured at 1.5
. The structural figures in the present study were rendered by using the program PYMOL (6).
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HapR, database searches were performed using both DALI
(18) and SSM (27). The top hits from the DALI search in-
cluded seven uncharacterized, putative transcription factors
whose structures have been determined by various structural
genomics initiatives (PDB codes 2HYJ, 2G3B, 1VI0, 1ZK8,
1SGM, 1Z77, and 2GFN; DALI aligned HapR chain A with
chain A of each of these). The eighth hit was a characterized
protein, the multidrug binding transcriptional regulator QacR
(42, 43). The SSM search also identified QacR as the most
homologous protein for which a thorough characterization has
been reported. Among the top SSM hits, the highest homology
was between chain B of the HapR structure and the drug-free
chains from a number of dimeric structures of QacR bound
with cationic, lipophilic drugs, including ethidium (PDB code
1JTY, chain E), malachite green (1JUP:E), hexamidine
(1RPW:D), berberine (1JUM:E), proflavine (1QVT:E), and
dequalinium (1JT6:E). Also high on the SSM list was the
drug-free, DNA-bound form of QacR (1JT0:B). For all of
these structures, SSM reported Q scores between 0.50 and
0.46, with root mean square deviation values of 2.17 Å to 2.40
Å for between 161 and 171 aligned alpha carbons.
Dimerization domain and interface. The dimerization inter-
face is one of the conserved structural features of the TetR
family and, as shown in Fig. 1B, in HapR forms by coupling 8
and 9 in one monomer to form a four-helix bundle with the
same helices of the other monomer, burying over 1,700 Å2.
Helices 8 and 9, which are 21 and 13 amino acids long and
pack in parallel to each other, are stabilized by many hydro-
phobic contacts involving Tyr194, Leu166, Leu154, Leu176,
Ala120, Tyr172, Trp127, and Leu181. Additional amino acid
contacts are provided by the loops connecting helices 1 and
2, helices 6 and 7, and helices 7 and 8. Notable among
these interactions, residues Arg37, Thr122, Arg123, and
His158 form both hydrophobic and polar contacts. Tyr172 in
helix 8 forms stacking interactions, and Cys199 in helix 9
forms a disulfide bridge with its complementary residue. Al-
though it is unlikely that this disulfide bond is formed in the
reducing environment of the cell interior, a similar disulfide
FIG. 2. Multiple sequence alignment of TetR family members and secondary structure assignment for HapR based on its crystal structure. The
HapR secondary structure is shown above the sequence. Residue numbering is to the right for all proteins and also above the secondary structure
elements for HapR. The sequences were aligned by using CLUSTAL W (4) and formatted using ESPript (15). Residues identical to HapR are
red, and residues identical in two or more family members are blue. The black boxes show the residues altered in the present study to alanine.
Conserved residues in the DNA-binding domain discussed in the text are highlighted in yellow, and residues in the putative binding pocket (shown
in Fig. 3C) are in highlighted in cyan. (Accession numbers are shown to the right of each line.) Vc, V. cholerae; Vh, V. harveyi; Mt, M. tuberculosis;
Sc, S. coelicolor; Sa, S. aureus; Ec, E. coli.
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bridge is present in the CprB structure via Cys159 on helix 8
between the two subunits (36). Other interesting interactions
include a water-mediated hydrogen bonding network between
Asp159 amide nitrogen of one monomer and Ser193 of the
other monomer and a salt bridge between Glu117 of one
monomer and Arg123 of the other monomer. The interactions
between these parallel helices are duplicated by the twofold
dimer symmetry, contributing to the stability of the HapR
dimer.
Putative ligand-binding domain. Several programs were
used to identify cavities and putative ligand-binding sites in the
HapR dimer. The program SURFNET (28) was used to visu-
alize cavities and showed a tunnel 3.0 Å in diameter leading
through the dimerization interface (Fig. 3A and B). Further-
more, in each monomer an amphipathic pocket is connected to
this tunnel. The pockets are essentially identical in each mono-
mer; however, in monomer A the pocket is solvent accessible,
whereas in monomer B rotation of the side chain of Gln138
partially blocks the opening between the tunnel and the
pocket. Analysis of the structure with the online program
CASTp (10) shows the Connolly/molecular surface-based vol-
ume of the tunnel and monomer A pocket combined to be
1412 Å3 and the volume of the isolated monomer B pocket to
be 130 Å3. In both monomers, this putative ligand-binding
domain is surrounded by polar amino acid side chains on one
side of the pocket, with hydrophobic residues on the opposite
side (Fig. 3C). Analysis of the overall surface electrostatics
(Fig. 3D) shows both the tunnel and the pockets to have a net
positive charge, indicating that the binding ligand is likely to be
amphipathic and contain anionic moieties. This is in marked
contrast to QacR, in which the ligand-binding pocket is able to
accommodate a structurally diverse set of cationic lipophilic
drugs whose binding is stabilized by glutamate side chains (44).
It should be noted that whereas all TetR family members
whose structures have been solved contain ligand-binding
pockets in a homologous location, the presence of a solvent
accessible tunnel is unique to HapR.
Since QacR showed the highest degree of structural similar-
ity to HapR, we compared our structure to two forms of QacR:
the drug-free, DNA-bound form, determined to 2.9-Å resolu-
FIG. 3. View of the solvent accessible tunnel and putative ligand-binding pocket of HapR. (A) Ribbon diagram of the HapR dimer, oriented
as in Fig. 1B, showing the location of the tunnel and cavity in blue, monomer A in magenta, and monomer B in green. The surfaces in this figure
were generated by using the program SURFNET (28) and rendered by using PYMOL (6). (B) Top view of the tunnel and cavities looking down
the HapR dimer interface. (C) View of residues containing atoms surrounding the solvent isolated pocket in monomer B. (D) Electrostatic surface
potential of the HapR dimer, oriented as in panel A. Blue and red indicate positive and negative charges, respectively. The black arrow points to
the electropositive entrance to the solvent accessible tunnel and pocket, visible slightly to the right of the center of the dimer. The electrostatic
surface was calculated by using the APBS (2) plug-in to PYMOL (6). Atomic charges and radii were calculated by using the AMBER force field
option at the online PDB2PQR service (8).
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tion (43), and the dequalinium-bound form, determined to
2.54-Å resolution (44). These two structures have been used to
provide a model as to how drug binding in QacR induces
structural changes resulting in its release from DNA (42). In
the drug-free structure of QacR bound to DNA, a binding
pocket of 400 Å3 is flanked by helices 5 and 6 (Fig. 4A).
Binding of a drug, such as dequalinium, induces a coil-to-helix
transition that lengthens helix 5 by one complete turn. This
has two primary results: two tyrosine residues, acting as “drug
surrogates,” are removed from the drug binding pocket,
thereby increasing its volume to 1,100 Å3, and helix 6
moves, resulting in a rotation and translation of the DNA-
binding domain. Comparison of HapR with these two confor-
mations shows some interesting similarities, as well as some
differences. Despite HapR being in a ligand-free state, helix 5
is extended, as in the drug-bound form of QacR (Fig. 4B).
However, the relative position of the HapR DNA-binding do-
main is similar to that of the DNA-bound form of QacR (Fig.
4C), and we predict that the HapR dimer is in a conformation
that would support DNA binding without significant confor-
mational changes (see below).
Although at first it appears that the structural logic de-
scribed for QacR has not been followed by HapR, the presence
of a kink in helix 7 provides an explanation for HapR having
an extended 5, as well as a binding-competent position of its
DNA-binding domain. The kink, which is significantly more
pronounced than the bend observed in QacR structures (Fig.
1A and B and Fig. 4B), allows helix 6 to remain in an “up”
position despite the presence of an extended helix 5. This
suggests a model in which drug binding to HapR induces re-
lease from DNA via a straightening of helix 7, rather than the
coil-to-helix transition in helix 5 observed in QacR. Loss of
the kink would produce a movement of 6 and the DNA-
binding domain into a position similar to that seen in drug-
bound QacR, resulting in a structure that could no longer bind
to DNA. While the absence in helix 5 of hydrophobic resi-
dues that could serve as “drug surrogates” also suggests that
HapR operates under a different specific mechanism from
QacR, it is interesting that the global changes are likely to be
similar for both proteins as they switch between conformations
that are able or unable to bind to DNA.
DNA-binding domain and model for HapR-DNA interac-
tion. The DNA-binding domain of HapR is composed of three
-helices, 1, 2 and 3, where helices 2 and 3 form a
typical HTH motif. The residues that form the hydrophobic
core of the DNA-binding domain (Leu22, Ala26, Phe30, I43,
V54, and Phe58) are fairly well conserved among family mem-
bers (Fig. 2). In both TetR (38) and QacR (43), helix 3 serves
as the recognition helix that interacts with the major groove of
target DNA. Similar to other family members, the C-terminal
end of helix 3 in HapR is rich in aromatic residues (Phe55,
Tyr57, and Phe58) (Fig. 2). Also, HapR contains a positively
charged Arg61 as the first residue in helix 4, a position in
which many other TetR family members have a conserved
lysine that has been shown to contact the phosphate backbone
in both TetR-DNA and QacR-DNA complexes (9).
To predict what interactions HapR is likely to have with
DNA, a model of the HapR-DNA complex was generated
(Fig. 5) by aligning the HapR dimer with the QacR dimer-
DNA structure (PDB code 1JT0, chains B and D) (43). Super-
position of the two dimers results in a very close alignment,
with 284 C atoms having an root mean square deviation of 2.3
Å. The alignment places the DNA-binding helices (2 and 3)
of HapR within 0.8 Å of the homologous helices in QacR, with
the two DNA-binding domains being only 1.5 Å farther apart
in the HapR dimer than in QacR. As expected, the DNA-
binding surface of HapR displays a dominantly electropositive
surface (Fig. 3D). The model predicts that residues in or near
helix 3, including Ser50, Val51, Ala52, Thr53, Phe55, and
Asn56, will form polar and/or hydrophobic contacts with the
major groove DNA bases, whereas residues Arg10, Arg12,
FIG. 4. Comparison of HapR with DNA-bound apo QacR and dequalinium-bound QacR. (A) SSM (27) produced superposition of DNA-
bound apo QacR (PDB 1JT0, chain B) shown in cyan and dequalinium-bound QacR (1JT6:A) shown in green. For clarity, only helices 5, 6, and
7 (amino acids 76 to 136) and the DNA-binding domain (amino acids 2 to 4) are shown. Note that in the dequalinium-bound QacR structure,
helix 5 is extended by a full turn, causing the DNA-binding domain to move in relation to helices 5 to 7, as indicated by the arrow.
(B) Alignment of HapR, shown in orange, and QacR-dequalinium, shown in green, showing that helix 5 is extended in both of these structures
to a similar degree and that the DNA-binding domains do not align. The pronounced kink in helix 7 of HapR is indicated. C, Alignment of HapR,
in orange, and apo QacR-DNA, in cyan, showing the close alignment of the DNA-binding domains.
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Arg18, Lys19, Arg33, Arg37, His40, and Arg61 are predicted to
interact with the phosphate backbone.
Mutational analysis of residues in helix 3. In order to
further characterize the structural interactions governing
DNA-binding affinity, two residues in helix 3 predicted to
form contacts with DNA, Thr53 and Phe55, were altered to
Ala. The mutant proteins were purified by using the same
method that was used for the wild-type protein (31), and their
ability to bind to DNA was assessed by using a gel mobility shift
assay with a fragment of the aphA promoter that encompasses
the HapR binding site. As shown in Fig. 6A, the wild-type
protein bound strongly to this fragment but, at the same con-
centrations of protein, the F55A mutant was completely de-
fective for binding, and the T53A mutant bound only very
weakly. These results indicate that both of these positions are
important for high-affinity binding of HapR to the aphA pro-
moter.
To determine whether the mutations also influenced the
ability of HapR to repress virulence gene expression and bio-
film formation in vivo, both mutations were introduced into the
chromosome of a V. cholerae aphA-lacZ promoter fusion
strain. Surprisingly, the T53A mutant retained the ability to
repress the expression of the aphA promoter similar to that of
wild-type HapR (Fig. 6B), whereas the F55A mutant was no
longer capable of repressing its expression and appeared sim-
ilar to that of a hapR mutant. Consistent with these results,
the F55A mutant exhibited a rugose colony morphology indic-
ative of the overexpression of the Vibrio polysaccharide genes
critical for biofilm formation that occurs when HapR is unable
to repress their expression (16). In contrast, the T53A mutant
showed a smooth colony morphology similar to the wild type.
These results indicate that Phe55 is a critical residue for HapR
binding to both the aphA and the vps promoters in vivo to
repress virulence and biofilm formation, respectively. It may
make a base-specific contact with DNA similar to that of the
analogous residue in QacR, Tyr40 (43). Another example of a
specific contact between an aromatic side chain and a nucleo-
tide base has been observed in the crystal structure of a mutant
form of the E. coli catabolite activator protein CAP-DNA
complex that shows a phenylalanine can effectively replace a
glutamate (E181) by forming a base-specific, aromatic hydro-
gen bond (39). Although the T53A mutation showed a defect
in the more stringent in vitro binding assay, the mutant re-
FIG. 5. Model of the HapR-DNA complex. A side view of the model
of the HapR dimer (one chain in cyan and the other in green) bound to
DNA is shown. The primary DNA interactions are predicted to be via
helix 3 (yellow), which fit into adjacent major grooves on the same face
of the DNA. The model was made by aligning the HapR dimer with the
QacR dimer-DNA structure (PDB code 1JT0, chains B and D).
FIG. 6. Mutational analysis of residues in HapR helix 3. (A) Binding of wild-type and mutant HapR proteins to the aphA promoter. Lane 1,
no protein added; lanes 2 to 5, wild-type HapR; lanes 6 to 9, HapR T53A; lanes 10 to 13, HapR F55A. The first lane in each set has 5 nM (2.5
ng) protein, the second lane has 50 nM (25 ng), the third lane has 200 nM (100 ng), and the fourth lane has 500 nM (250 ng). (B) Influence of
HapR mutations on the expression of an aphA-lacZ promoter fusion in V. cholerae. Strains were grown under AKI conditions (19) at 37°C for 3.5 h.
From left to right are shown GK178 (wt), KSK1815 (hapR), WL521 (T53A), and WL522 (F55A). (C) Western analysis of crude extracts (17.5
g) of the strains in panel B using anti-HapR antibody.
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tained the ability to repress the expression of the aphA and vps
promoters in vivo. Thus, this residue does not appear to be
critical for the DNA-binding activity of HapR in vivo.
Concluding remarks. Although HapR is not related to the
TraR-type of quorum-sensing regulator that responds directly
to autoinducer, the structure presented in the present study
reveals that HapR possesses a unique solvent accessible tunnel
that may accommodate an as-yet-unidentified small molecule
ligand. This raises the intriguing possibility that, in addition to
its regulation by quorum sensing, which influences its intracel-
lular levels, a second level of regulation may influence its
DNA-binding activity. For example, at high cell density, when
HapR levels are increased, the binding of a particular ligand to
HapR may induce conformational changes in the protein sim-
ilar to those observed in other TetR regulators, which releases
the protein from the DNA, thereby inducing the expression of
virulence and biofilm genes. Studies to identify a ligand are
currently in progress.
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